HAEMONETICS CORP — Director's Dealing 2019

May 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2019-05-21

Reporting Person: KROLL MARK W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-21	Common Stock	G	1449	—	Disposed	22157	Direct

Footnotes

F1: Shares transferred as a bona fide gift without any consideration.

F2: This number includes unvested restricted stock units previously reported.